Presentations November 7, 2024 Ventyx Corporate Presentation October 15, 2024 VTX002 Phase 2 LTE Presentation UEG Week 2024 June 5, 2024 VTX3232 Results of Diet-Induced Obese Mouse Model Studies March 11, 2024 Ventyx Virtual Investor Event February 22, 2024 VTX002 Phase 2 UC Oral Presentation ECCO 2024 October 9, 2023 VTX002 Phase 2 Ulcerative Colitis Results
